Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-11.21	74.99	84.45
Graham Fair Price	-12.04	26.52	30.14
PEG	102.69	-0.95	0.47
Price/Book	12.02	-11.67	-13.26
Price/Cash Flow	-28.47	75.29	105.25
Prices/Earnings	24.14	24.58	19.80
Price/Sales	-9.90	49.66	55.12
Price/FCF	-28.47	75.29	105.25
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.03	0.87	0.87
Operating Margin	-0.01	0.67	0.67
ROA	-25.77	0.11	0.15
ROE	-0.17	-0.12	29.12
ROIC	1.26	1.24	-1.73
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-77.32
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	< 0.005	0.01	28.99
EPS QOQ	0.42	-0.26	-38.76
FCF QOQ	-0.08	0.27	237.54
Revenue QOQ	0.01	0.01	-5.90
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	< 0.005	-1.22
Days Sales Outstanding (DSO)	3.22	1.85	-42.50
Inventory Turnover	48500000.00	49100000.00	1.24
Debt/Capitalization	8.38	11.22	33.97
Quick Ratio	0.79	0.77	-2.86
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-15.53	-16.23	-4.49
Cash	9.10	9.17	0.81
Capex	-0.05	-0.04	23.25
Free Cash Flow	1.96	2.51	28.52
Revenue	3.74	3.81	2.03
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.83	0.81	-2.09
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.84	3.96	-32.20
Naive Interpretation	Member

06 - Financial Health · Bad

Rating